8504 Background: Neoadjuvant immune checkpoint inhibitors (ICIs) induce major
pathologic response (MPR) rates of 20 to 45% in resected NSCLCs. We report the results of …

Limited clinical activity has been seen in osteosarcoma (OS) patients treated with immune
checkpoint inhibitors (ICI). To gain insights into the immunogenic potential of these tumors, we …

Osteosarcoma is the most common pediatric and adult primary malignant bone cancer.
Curative regimens target the folate pathway, downstream of serine metabolism, with high-dose …

Background Desmoplastic small round cell tumor (DSRCT) is an aggressive, often fatal soft
tissue sarcoma that lacks an optimal salvage regimen. We retrospectively reviewed data …

Objectives A rising number of patients with cancer are older adults (65 years of age and older),
and this proportion will increase to 70% by the year 2020. Falls are a common condition …

Purpose Metastatic phyllodes tumors of the breast (MPT) are rare breast neoplasms, limiting
development of standardized treatment approaches. We sought to characterize the largest …

Background QT prolongation and torsades de pointes pose a major concern for cardiologists
and oncologists. Although cancer patients are suspected to have prolonged QT intervals, …

Chemotherapy-induced autophagy is a proposed mechanism of chemoresistance and
potential therapeutic target in osteosarcoma. We evaluated heat shock protein 27 (HSP27) and …

Introduction/objectives The effects of biologic disease–modifying antirheumatic drugs (bDMARDs)
in patients with rheumatoid arthritis (RA) and cancer are largely unknown. We …

We aimed to study the utility of the FRAX tool in predicting fractures in patient’s receiving a
hematopoietic stem cell transplantation (HSCT). Our results indicate that the FRAX tool has …